Bausch Health
Bookmark
ShareCopied to clipboardBausch Health is a company. It is a public company in Laval, Canada. It was founded in 1960 and its current CEO is Thomas J. Appio. It is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Key facts
- city: Laval
- country: Canada
- employees: 20,700 people
- revenues: 9.6B $
- company type: public
- sector: Health Care
- industry: Pharmaceuticals
- foundation year: 1960
- CEO: Thomas J. Appio
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about Bausch Health:
Dataset of stocks from Bausch Health:
Bausch Health is one of the companies in Canada, companies in Pharmaceuticals, companies in Health Care, companies in Laval and 3,456,808 companies in our database.
Talking Points
- Learn about Bausch Health, a global company whose mission is to improve people’s lives with our health care products.
- Our mission is to improve people’s lives with our health care products worldwide. See our Community Guidelines: https://t.co/v6KYZmtBh6
- Improving People's Lives with our Health Care Products | Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.